PLA2G7 and coronary artery disorder: Similarly, in the PROSPER (The Prospective Study of Pravastatin in the Elderly at Risk) trial only Lp-PLA2 mass was found to be significantly related to future CHD risk, while no association was found for enzyme activity after controlling for various confounders [41].